Lansoprazole
- Product NDC
- 55154-4848
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lansoprazole
- Dosage form
- TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Cardinal Health 107, LLC
- Application
- ANDA208784
- Marketing category
- ANDA
- Substance
- LANSOPRAZOLE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 55154-4848-0 | 10 BLISTER PACK in 1 BAG (55154-4848-0) / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK | 20180308 | | No | Historical |
Related DailyMed Labels
| Set ID | Title | Manufacturer | Effective date | Type | Version |
|---|
| c9a43df0-efab-4486-860f-92afdb258c8b | These highlights do not include all the information needed to use LANSOPRAZOLE DELAYED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LANSOPRAZOLE DELAYED-RELEASE ORALLY DISINTEGRATING TABLETS. LANSOPRAZOLE delayed-release orally disintegrating tablets Initial U.S. Approval: 1995 | Cardinal Health 107, LLC | 2025-10-17 | HUMAN PRESCRIPTION DRUG LABEL | 4 |
| c9a43df0-efab-4486-860f-92afdb258c8b | These highlights do not include all the information needed to use LANSOPRAZOLE DELAYED-RELEASE ORALLY DISINTEGRATING TABLETS safely and effectively. See full prescribing information for LANSOPRAZOLE DELAYED-RELEASE ORALLY DISINTEGRATING TABLETS. LANSOPRAZOLE delayed-release orally disintegrating tablets Initial U.S. Approval: 1995 | Cardinal Health 107, LLC | 2024-09-23 | HUMAN PRESCRIPTION DRUG LABEL | 3 |